Trial in Adult Subjects With Acute Migraines

clinical trial

Wikidata entity: Q64801678



Quantities

P2899minimum age18
P1132number of participants1812

P6099 clinical trial phase ... Q42824827 (phase III clinical trial) phase III clinical trial
P17 country ... Q30 (United States) United States
P582 end time ... 2018-10-08 ???
P31 instance of ... Q30612 (clinical trial) clinical trial
P6153 research site ... Q49112 (Yale University) Yale University
P6153 research site ... Q50035554 (Pharmacology Research Institute) Pharmacology Research Institute
P6153 research site ... Q30269657 (Coastal Carolina Research Center) Coastal Carolina Research Center
P6153 research site ... Q30269674 (Collaborative Neuroscience Network) Collaborative Neuroscience Network
P6153 research site ... Q30269704 (Meridien Research) Meridien Research
P6153 research site ... Q30269845 (Diablo Clinical Research) Diablo Clinical Research
P6153 research site ... Q30269903 (Heartland Research Associates) Heartland Research Associates
P6153 research site ... Q30270033 (PMG Research) PMG Research
P6153 research site ... Q30270193 (Meridian Clinical Research) Meridian Clinical Research
P6153 research site ... Q30270494 (Synexus (Germany)) Synexus (Germany)
P6153 research site ... Q30282378 (Northwest Clinical Research Center) Northwest Clinical Research Center
P6153 research site ... Q30298472 (Radiant Research (United States)) Radiant Research (United States)
P580 start time ... 2018-02-27 ???
P8363 study type ... Q78089383 (interventional study) interventional study
P1476 title Monolingualtext BHV3000-303: Phase 3, Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Migraine ???

External Ids
P3098ClinicalTrials.gov IDNCT03461757

Why not click here or view trends?

log id: 5754525